drugset / Trial / NCT00446979
Safety Study of UC-781 Vaginal Microbicide
Phase 1
Completed
90 enrolled
Centers for Disease Control and Prevention
CONRAD · collabMinistry of Health, Thailand · collab
RandomizedParallel-groupQuadruple-blindPrevention
Summary
This study will help determine whether UC-781 gel is safe when applied to the vagina twice daily for 14 days, and will assess whether women and men find the gel acceptable to use.
Timeline
- Start
- 2007-06
- Primary completion
- —
- Completion
- 2007-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | UC-781 | Small molecule | 0.1 % | Other |
| Subject | UC-781 | Small molecule | 0.25 % | Other |